3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
291
Carcinoma, Non-Small-Cell Lung
206
Prostatic Neoplasms
158
Lung Neoplasms
93
Stomach Neoplasms
69
Neoplasms
69
Head and Neck Neoplasms
60
Squamous Cell Carcinoma of Head and Neck
56
Neoplasm Metastasis
50
Esophageal Neoplasms
49
Ovarian Neoplasms
39
Pancreatic Neoplasms
26
Sarcoma
23
Carcinoma, Ovarian Epithelial
20
Urinary Bladder Neoplasms
19
Unspecified Adult Solid Tumor, Protocol Specific
19
Breast Neoplasms, Male
17
Adenocarcinoma Of Esophagus
17
Parkinson Disease 4, Autosomal Dominant Lewy Body
16
Esophageal Squamous Cell Carcinoma
16
Adenocarcinoma of Lung
16
Fallopian Tube Neoplasms
14
Carcinoma, Squamous Cell
14
Adenocarcinoma
12
Melanoma
11
Inflammatory Breast Neoplasms
11
Uterine Cervical Neoplasms
9
Triple Negative Breast Neoplasms
9
Salivary Gland Neoplasms
8
Endometrial Neoplasms
8
Interventions
Voriconazole
4
Vancomycin
3
Fluconazole
3
Filgrastim
3
Ciprofloxacin
3
Caspofungin
3
liposomal amphotericin B
2
Trimethoprim, Sulfamethoxazole Drug Combination
2
Therapeutics
2
Piperacillin, Tazobactam Drug Combination
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Itraconazole
2
Granulocyte Colony-Stimulating Factor
2
Fosfomycin
2
Daptomycin
2
Cyclophosphamide
2
Cefazolin
2
Antibiotic Prophylaxis
2
ziprasidone
1
threonic acid
1
telavancin
1
soybean oil, phospholipid emulsion
1
plerixafor
1
monalizumab
1
lime
1
human papillomavirus vaccine, L1 type 16, 18
1
fluorescein isothiocyanate-keyhole limpet hemocyanin
1
fludarabine phosphate
1
fish oil triglycerides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Infections
×
Docetaxel
×
Clear all
NCT04324346
2021-03-18
PICC&PAC
Swedish Red Cross University College
Phase NA
Completed
250 enrolled